Madely Health Headlines Commentary for October 16, 2012
Source:
Abbott Labs rises on hepatitis C drug data
Reference:
This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. There is no obligation on the part of pharma to release details of stiudies that cast a negative outcome for their product.